Exercise Improves Leg Pain Caused by Arterial Disease
Posted on: Monday, 2 February 2009, 10:38 CST
Patients with leg pain caused by arterial disease may be able to forego treatment of the affected artery by participating in hospital-supervised exercise, according to a new study published in the February issue of Radiology.Intermittent claudication is a painful leg condition affecting some patients with peripheral arterial disease. Various treatments are available, including drug therapy or endovascular revascularization, a minimally invasive technique that widens and restores blood flow to the affected artery.
"The results from our clinical trial demonstrate that after six and 12 months, patients with intermittent claudication benefited equally from either revascularization or supervised exercise," said the study's lead author, Sandra Spronk, Ph.D., researcher in the Department of Epidemiology and Radiology at Erasmus MC, University Medical Center in Rotterdam, Netherlands . "However, improvement is more immediate following revascularization."
For the study, 151 patients with intermittent claudication were randomly assigned to undergo revascularization or hospital-supervised exercise. Supervised exercise consisted of 30-minute, semi-weekly sessions of walking on a treadmill. Follow-up was performed after six and 12 months.
The patients who had undergone revascularization showed more immediate improvement. However, no significant differences were observed between the two groups after six months or 12 months with functional capacity and quality of life scores increasing for all patients.
"Revascularization is increasingly being performed as a first line of treatment," Dr. Spronk said. "This study emphasizes that all patients with intermittent claudication should initially be treated with exercise training, and that invasive procedures should be considered only if symptoms fail to improve."
-------
On The Net:
Radiological Society of North America
Related Articles
- Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
- MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
- XTL Completes Patient Randomization in Phase IIb Study of Diabetic Pain Drug
- Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
- First of Its Kind Study Finds Patients Report Looking an Average of Five to Six Years Younger Following BOTOX(R) Cosmetic Treatment for Upper Facial Lines
- Synthetic Blood Updates Traumatic Brain Injury Trial Enrollment; Six of Eight Patients Treated in Phase II Study
- Javelin Treats First Patient in Phase III Pain Study
- Six Minutes of Exercise Can Be As Healthy As Six Hours
- Patient Deaths Decline in Early Studies of New Cancer Drugs More-Targeted Drugs, More Emphasis on Patient Safety Cited in Minimizing Risk
- Patient Dies in VA Medical Study
Rating: 2.5 / 5 (6 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds